For the first time, cervical cancer screening guidelines from the U.S. Preventive Services Task Force include self-collection ...

Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups.

The U.S. Preventative Services Task Force has drafted a new recommendation for cervical cancer screening. The biggest change: ...

Women with HPV type 16 and a low Ct value (<30) had the highest risk of severe cervical precancer or cancer. About 40 % of women in our high-risk group had been diagnosed with the severe cervical ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred ...

The HPV vaccine has led to a significant drop in cervical cancer deaths among younger women, with a 62 percent decline in ...

For patients ages 40-49, cancer treatment rates increased 18.2% for colorectal cancer, 11.2% for cancers of the digestive system and 8% for HPV-related cancers between 2016 and 2023. Among all cancer ...

Cancer treatment rates jumped among adults younger than age 50 between 2020 and 2023, according to a FAIR Health analysis ...

A pair of tests approved by the FDA in July give women the opportunity to collect their own samples in medical settings – similar to the way urine tests are handled.

"It's not just treatment advances alone, or prevention and screening alone, that is helping us to reduce cancer mortality." ...

Routine cervical cancer screening typically requires patients to receive Pap smears every three years. On Dec. 10, a national task force put forth a new screening recommendation for women 30 and older ...